536 related articles for article (PubMed ID: 9889194)
1. Mutational analyses of the SOCS proteins suggest a dual domain requirement but distinct mechanisms for inhibition of LIF and IL-6 signal transduction.
Nicholson SE; Willson TA; Farley A; Starr R; Zhang JG; Baca M; Alexander WS; Metcalf D; Hilton DJ; Nicola NA
EMBO J; 1999 Jan; 18(2):375-85. PubMed ID: 9889194
[TBL] [Abstract][Full Text] [Related]
2. A family of cytokine-inducible inhibitors of signalling.
Starr R; Willson TA; Viney EM; Murray LJ; Rayner JR; Jenkins BJ; Gonda TJ; Alexander WS; Metcalf D; Nicola NA; Hilton DJ
Nature; 1997 Jun; 387(6636):917-21. PubMed ID: 9202125
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory roles for SHP-1 and SOCS-3 following pituitary proopiomelanocortin induction by leukemia inhibitory factor.
Bousquet C; Susini C; Melmed S
J Clin Invest; 1999 Nov; 104(9):1277-85. PubMed ID: 10545526
[TBL] [Abstract][Full Text] [Related]
4. CIS3 and JAB have different regulatory roles in interleukin-6 mediated differentiation and STAT3 activation in M1 leukemia cells.
Suzuki R; Sakamoto H; Yasukawa H; Masuhara M; Wakioka T; Sasaki A; Yuge K; Komiya S; Inoue A; Yoshimura A
Oncogene; 1998 Oct; 17(17):2271-8. PubMed ID: 9811457
[TBL] [Abstract][Full Text] [Related]
5. Identification of critical residues required for suppressor of cytokine signaling-specific regulation of interleukin-4 signaling.
Haque SJ; Harbor PC; Williams BR
J Biol Chem; 2000 Aug; 275(34):26500-6. PubMed ID: 10950967
[TBL] [Abstract][Full Text] [Related]
6. Pituitary corticotroph SOCS-3: novel intracellular regulation of leukemia-inhibitory factor-mediated proopiomelanocortin gene expression and adrenocorticotropin secretion.
Auernhammer CJ; Chesnokova V; Bousquet C; Melmed S
Mol Endocrinol; 1998 Jul; 12(7):954-61. PubMed ID: 9658400
[TBL] [Abstract][Full Text] [Related]
7. Suppressors of cytokine signalling: SOCS.
Larsen L; Röpke C
APMIS; 2002 Dec; 110(12):833-44. PubMed ID: 12645661
[TBL] [Abstract][Full Text] [Related]
8. SOCS proteins: modulators of neuroimmunoendocrine functions. Impact on corticotroph LIF signaling.
Auernhammer CJ; Bousquet C; Chesnokova V; Melmed S
Ann N Y Acad Sci; 2000; 917():658-64. PubMed ID: 11268394
[TBL] [Abstract][Full Text] [Related]
9. Structure and function of a new STAT-induced STAT inhibitor.
Naka T; Narazaki M; Hirata M; Matsumoto T; Minamoto S; Aono A; Nishimoto N; Kajita T; Taga T; Yoshizaki K; Akira S; Kishimoto T
Nature; 1997 Jun; 387(6636):924-9. PubMed ID: 9202127
[TBL] [Abstract][Full Text] [Related]
10. Role of suppressors of cytokine signaling (Socs) in leukemia inhibitory factor (LIF) -dependent embryonic stem cell survival.
Duval D; Reinhardt B; Kedinger C; Boeuf H
FASEB J; 2000 Aug; 14(11):1577-84. PubMed ID: 10928992
[TBL] [Abstract][Full Text] [Related]
11. Interleukin 9 induces expression of three cytokine signal inhibitors: cytokine-inducible SH2-containing protein, suppressor of cytokine signalling (SOCS)-2 and SOCS-3, but only SOCS-3 overexpression suppresses interleukin 9 signalling.
Lejeune D; Demoulin JB; Renauld JC
Biochem J; 2001 Jan; 353(Pt 1):109-116. PubMed ID: 11115404
[TBL] [Abstract][Full Text] [Related]
12. LIF-induced STAT3 signaling in murine versus human embryonal carcinoma (EC) cells.
Schuringa JJ; van der Schaaf S; Vellenga E; Eggen BJ; Kruijer W
Exp Cell Res; 2002 Mar; 274(1):119-29. PubMed ID: 11855863
[TBL] [Abstract][Full Text] [Related]
13. Cutting edge: SOCS-1 is a potent inhibitor of IL-4 signal transduction.
Losman JA; Chen XP; Hilton D; Rothman P
J Immunol; 1999 Apr; 162(7):3770-4. PubMed ID: 10201892
[TBL] [Abstract][Full Text] [Related]
14. gp130-Dependent signalling pathway is not enhanced in gp130 transgenic heart after LIF stimulation.
Tone E; Kunisada K; Kumanogoh A; Negoro S; Funamoto M; Osugi T; Kishimoto T; Yamauchi-Takihara K
Cytokine; 2000 Oct; 12(10):1512-8. PubMed ID: 11023666
[TBL] [Abstract][Full Text] [Related]
15. Cloning and functional analysis of new members of STAT induced STAT inhibitor (SSI) family: SSI-2 and SSI-3.
Minamoto S; Ikegame K; Ueno K; Narazaki M; Naka T; Yamamoto H; Matsumoto T; Saito H; Hosoe S; Kishimoto T
Biochem Biophys Res Commun; 1997 Aug; 237(1):79-83. PubMed ID: 9266833
[TBL] [Abstract][Full Text] [Related]
16. The suppressors of cytokine signalling (SOCS).
Kile BT; Alexander WS
Cell Mol Life Sci; 2001 Oct; 58(11):1627-35. PubMed ID: 11706989
[TBL] [Abstract][Full Text] [Related]
17. Three distinct domains of SSI-1/SOCS-1/JAB protein are required for its suppression of interleukin 6 signaling.
Narazaki M; Fujimoto M; Matsumoto T; Morita Y; Saito H; Kajita T; Yoshizaki K; Naka T; Kishimoto T
Proc Natl Acad Sci U S A; 1998 Oct; 95(22):13130-4. PubMed ID: 9789053
[TBL] [Abstract][Full Text] [Related]
18. Distinct activities of suppressor of cytokine signaling (SOCS) proteins and involvement of the SOCS box in controlling G-CSF signaling.
van de Geijn GJ; Gits J; Touw IP
J Leukoc Biol; 2004 Jul; 76(1):237-44. PubMed ID: 15107455
[TBL] [Abstract][Full Text] [Related]
19. Src family kinase-independent signal transduction and gene induction by leukemia inhibitory factor.
Laszlo GS; Nathanson NM
J Biol Chem; 2003 Jul; 278(30):27750-7. PubMed ID: 12764151
[TBL] [Abstract][Full Text] [Related]
20. Tyrosine-phosphorylated SOCS-3 inhibits STAT activation but binds to p120 RasGAP and activates Ras.
Cacalano NA; Sanden D; Johnston JA
Nat Cell Biol; 2001 May; 3(5):460-5. PubMed ID: 11331873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]